Number of Employees: Approximately 449
Nacional, Marlboro, Next, Lider
Welcome to Philip Morris Dominicana, Philip Morris International’s (PMI) affiliate in the Dominican Republic. We are the largest tobacco company in the country and we are proud to have been able to offer quality products to Dominican adult smokers for more than 40 years.
Our history in the Dominican Republic dates back to 1969 when Philip Morris International entered into a licensing agreement with the E. León Jimenes Company to manufacture Philip Morris International products in the Dominican Republic and sell them across the Caribbean. In 2006 PMI divested itself from the company’s other business’ and took over the cigarette business. Today, our factory in Santiago produces Nacional, Marlboro, Next, and Lider for the local market, as well as Marlboro, Raffles, Bond Street, and Longbeach for export to other Caribbean countries.
Philip Morris Dominicana supports programs for the prevention of tobacco use among young people. Periodically, our sales team distributes material to retailers to raise awareness of the penalties for selling to minors.
We also support important community programs such as the Young Farmers Training program (FORJA). This program, founded in 1999, focuses on teaching young farmers technical and managerial skills.
Smoking and Health
Tobacco products, including cigarettes, are dangerous and addictive. There is overwhelming medical and scientific evidence that smoking causes lung cancer, heart disease, emphysema, and other serious diseases.
All tobacco products are addictive. It can be very difficult to quit smoking, but this should not deter smokers who want to quit from trying to do so.
Public health officials have concluded that secondhand smoke from cigarettes causes serious diseases in non-smokers, including lung cancer and heart disease. We believe the public health conclusions on secondhand smoke are sufficient to support smoking restrictions in public places.
Philip Morris International (PMI) supports comprehensive regulation of tobacco products based on the principle of harm reduction.
To be effective, tobacco regulatory policy must be evidence-based, apply to all tobacco products, and should take into account the views of all legitimate stakeholders including public health authorities, government finance authorities, tobacco manufacturers, and other members of the tobacco supply chain. Regulatory policy must consider the potential to trigger adverse consequences which undermine public health objectives, such as increasing the demand for illicit cigarettes.
While we support comprehensive, effective tobacco regulation, we do not support regulation that prevents adults from buying and using tobacco products or that imposes unnecessary impediments to the operation of the legitimate tobacco market. In that regard, we oppose measures such as generic packaging, point of sale display bans, total bans on communications to adult consumers, and bans on the use of all ingredients in tobacco products.